Evidence map›Paper›PMID 42746235›Full record

ArticleAddiction & health2026

The effect of cognitive hypnotherapy on preventing relapse to opium use in men under methadone treatment.

Mansoureh Haidari, Zolaykha Karamelahi, Mohammad Zaman Kamkar

Abstract read
In one paragraph

Article in Addiction & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mansoureh HaidariDepartment of Psychiatry, Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran.
Zolaykha KaramelahiClinical Research Development Unit (CRDU)5 Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran.ORCID https://orcid.org/0000-0002-5875-330X
Mohammad Zaman KamkarDepartment of Psychiatry, Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran.ORCID https://orcid.org/0000-0003-4614-1194

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Opium addiction is a global problem that is difficult to overcome and has a high relapse rate. Some studies have shown the effect of hypnosis in helping control withdrawal symptoms and reduce relapse. The present study aimed to investigate the effect of cognitive hypnotherapy on preventing relapse to opium use in men under methadone treatment. Methods: This clinical trial was conducted on 34 opium addicts who were admitted to the Addiction Center of 5 AZAR GORGAN Hospital in 2024. The study population was selected from the referring patients using convenience sampling and was randomly assigned into two groups (methadone plus hypnosis) and a control (methadone only). Participants with negative urine were included in the study. Cognitive hypnotherapy was conducted, including 8 sessions (60 minutes) once a week. For all samples (intervention and control), before and after the intervention, 3 and 6 months later, a morphine test was performed, and questionnaires were completed using the Ernest Barratt Impulsiveness Scale and the Substance Craving Scale. The data were analyzed using SPSS-19 software. The significance level was considered at Findings: The rate of relapse in opium use and the mean impulsivity score in all of its dimensions in the hypnotherapy group was lower than that in the control group after the intervention, three and six months later, though it was not statistically significant ( Conclusion: Cognitive hypnotherapy can help reduce the desire to use opiate drugs.

Indexed as

Cognitive hypnotherapyMethadoneOpium

Identifiers

PMID42746235
PMCPMC13575660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.